BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2025 Earnings Call Transcript

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2025 Earnings Call Transcript May 1, 2025

BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $1.13, expectations were $0.94.

Operator: Good day, everyone, and welcome to the BioMarin Pharmaceuticals First Quarter 2025 Conference Call. Just a reminder that this conference is being recorded. I would now like to hand things over to Ms. Traci McCarty. Please go ahead, Ma’am.

Traci McCarty: Thank you, operator. To remind you,...